semaglutide glp-1 medication Specialist Near Me in San Antonio, TX GLP-1 pills are on the

Key Takeaway: ASC30s Phase 2 performance reinforces its promise as a competitive next-generation oral GLP-1 therapy with strong efficacy and differentiated tolerabilitypositioning Ascletis as a rising contender in a rapidly intensifying obesity drug landscape

Alcohol Management: If you must drink, stick to skinny options

Your provider can assess whether symptoms represent expected medication effects, require additional investigation such as upper endoscopy, or necessitate treatment modification

scores range from 0 to 100, with higher scores indicating fewer symptoms and physical limitations) and the change in body weight Results: Primary outcome (change in KCCQ-CSS score): Semaglutide +13.7, Placebo +6.4 (p 20 g (women) 30 g (men) Hepatic decompensation AST or ALT level 5 X ULN eGFR 9.5%